ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues related to implementation of US-Korea Free Trade Agreement Issues related to trade protections in Trans Pacific Partnership Discussions regarding US-EU Trade Liberalization Agreement
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRADLEY ALLEN ROSSIN | — |
Taxation/Internal Revenue Code TAX
Issues related to reform of tax code and possible timing of any such reform bill (no bill number yet)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRADLEY ALLEN ROSSIN | — |
| HEATHER STRAWN | — |
Medicare/Medicaid MMM
HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D administration Issues related to the Medicaid rebate formula
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA JOLIVETTE | — |
| ANDREW KAPLAN | — |
| JACQUELINE POMFRET KIRBY | — |
| BELA SASTRY | — |
| HEATHER STRAWN | — |
Copyright/Patent/Trademark CPT
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 issues related to the development of antibiotics S. 27 and related legislative proposals regarding possible restrictions on patent settlements HR 6353 and related legislative proposals regarding possible changes to tax law regarding intellectual property profits H.R. 6621 and related legislative proposals regarding technical fixes in patent reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARRIE HARNEY | — |
| THERESA JOLIVETTE | — |
| ANDREW KAPLAN | — |
Health Issues HCR
H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 issues related to the development of antibiotics Issues related to drug safety, supply chain, and facility inspections (No assigned legislation) Issues related to federal purchases under the Trade Agreements Act HR 6611 and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting Issues related to federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to healthcare exchanges and essential health benefits
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARRIE HARNEY | — |
| THERESA JOLIVETTE | — |
| ANDREW KAPLAN | — |
| JACQUELINE POMFRET KIRBY | — |
| BELA SASTRY | — |
| HEATHER STRAWN | — |
Consumer Issues/Safety/Products CSP
Issues related to drug safety, supply chain, and facility inspections (No assigned legislation) HR 6611 and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARRIE HARNEY | — |
| THERESA JOLIVETTE | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN | — |
Pharmacy PHA
S. 2295, H.R. 4384 and related legislation regarding pharmaceutical labeling changes
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEATHER STRAWN | — |
Medical/Disease Research/Clinical Labs MED
HR 1513, S 810 and related legislative proposals regarding the use of primates in clinical research
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARRIE HARNEY | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.